Playback speed
10 seconds
Off-Label Use of Biologics: Apremilast and Dupilumab
By
[PRIVATE] 2022 AAD Annual Meeting Coverage
FEATURING
David Rosmarin
By
[PRIVATE] 2022 AAD Annual Meeting Coverage
FEATURING
David Rosmarin
789 views
April 12, 2022
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY